medicallessons.net
FDA Approves New Assay for Her2 in Breast Cancer
This week the FDA approved a new assay for Her2 expression in breast cancer biopsies. The technology, Inform Dual ISH, is manufactured by Ventana Medical Systems, a Roche subsidiary. Inform Dual IS…
